Elevated 1-Year Mortality Rate in Males Sustaining Low-Energy Proximal Femur Fractures and Subgroup Analysis

Kyle A Schultz1, Benjamin A Westcott1, Kimberly R Barber2

  • 1Department of Orthopedics, Ascension Genesys Hospital, Grand Blanc, MI, USA.

Insights

Men with low-energy femur fractures face higher mortality risk than women. This is linked to poorer overall health status (age-adjusted Charlson comorbidity index) in men, impacting recovery from these common fractures.

Area of Science:

  • Orthopedic Surgery
  • Geriatric Medicine
  • Public Health

Background:

  • Low-energy proximal femur fractures are a significant health concern in the aging population.
  • Identifying patients at increased mortality risk is crucial for surgical decision-making.
  • Gender disparities in mortality following these fractures require investigation.

Purpose of the Study:

  • To evaluate gender differences in 1-year mortality after low-energy proximal femur fractures.
  • To analyze the impact of fracture location, age, and comorbidities on mortality.
  • To identify specific subgroups of patients at higher risk.

Main Methods:

  • Retrospective analysis of patients ≥40 years with proximal femur fractures (2014-2017).
  • Comorbidities identified using ICD-9/10 codes for age-adjusted Charlson comorbidity index (ACCI) calculation.
  • Mortality within 1 year of injury determined via county clerk database; statistical comparisons between genders performed.

Main Results:

  • Women sustained fractures at nearly 3:1 ratio to men.
  • Men presented with a significantly higher ACCI (5.35 vs 4.86).
  • Men had increased 1-year mortality for all fractures (31.3% vs 21.5%) and intertrochanteric fractures (36.2% vs 22.9%).

Conclusions:

  • Men with low-energy femur fractures exhibit a higher mortality risk compared to women.
  • Men's poorer baseline health status (higher ACCI) may contribute to increased fracture risk and impaired recovery.
  • Findings emphasize the need for tailored risk assessment and management strategies for male patients.
Abstract